Phase 1 Cancer Cachexia Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study of JMT203 in Patients With Cancer Cachexia

Pancreatic CancerNon-small Cell Lung CancerCancer Cachexia+2 more

Shanghai JMT-Bio Inc.307 enrolled1 locationNCT06868849

Recruiting

Phase 1

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants

Cancer cachexia syndromeCancer CachexiaCancer Cachexia (CC)

Shenzhen Kexing Pharmaceutical Co., Ltd.36 enrolled1 locationNCT07237464

Recruiting

Phase 1

A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia

Cancer Cachexia

Genfleet Therapeutics (Shanghai) Inc.36 enrolled1 locationNCT06898255